Roger Song
Stock Analyst at Jefferies
(1.04)
# 3,661
Out of 4,876 analysts
46
Total ratings
32.43%
Success rate
-14.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERV Verve Therapeutics | Downgrades: Hold | $28 → $11 | $11.31 | -2.70% | 1 | Jun 18, 2025 | |
| CVAC CureVac | Downgrades: Hold | $7 → $5 | $5.36 | -6.72% | 1 | Jun 13, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Buy | $40 → $45 | $28.35 | +58.73% | 2 | Apr 29, 2025 | |
| NKTR Nektar Therapeutics | Upgrades: Buy | $15 → $30 | $26.77 | +12.09% | 11 | Apr 11, 2025 | |
| AKBA Akebia Therapeutics | Initiates: Buy | $6 | $3.62 | +65.75% | 1 | Apr 1, 2025 | |
| SANA Sana Biotechnology | Initiates: Buy | $7 | $2.80 | +150.00% | 1 | Mar 14, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $245 | $138.63 | +76.73% | 1 | Mar 5, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $26 | $6.64 | +291.86% | 1 | Feb 25, 2025 | |
| IGMS IGM Biosciences | Downgrades: Hold | $48 → $2 | $1.20 | +66.67% | 2 | Jan 10, 2025 | |
| BIOA BioAge Labs | Downgrades: Hold | $42 → $7 | $4.17 | +67.87% | 2 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $19 | $9.27 | +104.96% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $28 | $5.75 | +386.96% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2 → $7 | $1.44 | +386.11% | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $89 | $55.22 | +61.19% | 1 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $25 | $6.34 | +294.32% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $41 | $11.65 | +252.08% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $9.82 | +256.60% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $4.94 | +82.19% | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $129 | $33.11 | +289.61% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2.5 → $8 | $2.35 | +240.43% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $97 | $80.38 | +20.68% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $72 | $16.48 | +337.03% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $26.48 | +315.41% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $35 | $3.50 | +900.00% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.83 | +989.72% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $3.88 | +106.45% | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $0.76 | +2,663.16% | 1 | Sep 2, 2020 |
Verve Therapeutics
Jun 18, 2025
Downgrades: Hold
Price Target: $28 → $11
Current: $11.31
Upside: -2.70%
CureVac
Jun 13, 2025
Downgrades: Hold
Price Target: $7 → $5
Current: $5.36
Upside: -6.72%
Kiniksa Pharmaceuticals International,
Apr 29, 2025
Maintains: Buy
Price Target: $40 → $45
Current: $28.35
Upside: +58.73%
Nektar Therapeutics
Apr 11, 2025
Upgrades: Buy
Price Target: $15 → $30
Current: $26.77
Upside: +12.09%
Akebia Therapeutics
Apr 1, 2025
Initiates: Buy
Price Target: $6
Current: $3.62
Upside: +65.75%
Sana Biotechnology
Mar 14, 2025
Initiates: Buy
Price Target: $7
Current: $2.80
Upside: +150.00%
Krystal Biotech
Mar 5, 2025
Initiates: Buy
Price Target: $245
Current: $138.63
Upside: +76.73%
Wave Life Sciences
Feb 25, 2025
Initiates: Buy
Price Target: $26
Current: $6.64
Upside: +291.86%
IGM Biosciences
Jan 10, 2025
Downgrades: Hold
Price Target: $48 → $2
Current: $1.20
Upside: +66.67%
BioAge Labs
Dec 9, 2024
Downgrades: Hold
Price Target: $42 → $7
Current: $4.17
Upside: +67.87%
Dec 4, 2024
Maintains: Buy
Price Target: $16 → $19
Current: $9.27
Upside: +104.96%
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $5.75
Upside: +386.96%
Nov 19, 2024
Upgrades: Buy
Price Target: $2 → $7
Current: $1.44
Upside: +386.11%
Oct 23, 2024
Initiates: Buy
Price Target: $89
Current: $55.22
Upside: +61.19%
Oct 16, 2024
Maintains: Buy
Price Target: $31 → $25
Current: $6.34
Upside: +294.32%
Oct 11, 2024
Initiates: Buy
Price Target: $41
Current: $11.65
Upside: +252.08%
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $9.82
Upside: +256.60%
Sep 5, 2024
Initiates: Buy
Price Target: $9
Current: $4.94
Upside: +82.19%
Sep 3, 2024
Maintains: Buy
Price Target: $108 → $129
Current: $33.11
Upside: +289.61%
May 6, 2024
Upgrades: Buy
Price Target: $2.5 → $8
Current: $2.35
Upside: +240.43%
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $80.38
Upside: +20.68%
Mar 20, 2024
Maintains: Buy
Price Target: $41 → $72
Current: $16.48
Upside: +337.03%
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $26.48
Upside: +315.41%
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $3.50
Upside: +900.00%
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $0.83
Upside: +989.72%
Dec 1, 2021
Initiates: Buy
Price Target: $8
Current: $3.88
Upside: +106.45%
Sep 2, 2020
Initiates: Buy
Price Target: $21
Current: $0.76
Upside: +2,663.16%